Synchroneuron

Improved formulation of acamprosate calcium for neurpschiatry disorders

placeNewton, Massachusetts, United States calendar_todayFounded 2006 groups1 employees language synchroneuron.com

Innovation

11 patent families (10 granted) — focus: Human necessities; filing pace slowing. Cited 1,764 times.

YearFilings
20121
20132
20142
20153
20163
20173
20192
20203
20212
20223
20251

Investor mix

2 investors on record; lead investors include Morningside.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon